Funding for this research was provided by:
Takeda Science Foundation
Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research (26461469, 16K19085, 26461468, 26713036)
Yokohama Foundation for Advancement of Medical Science
The Naito Memorial Foundation
The Uehara Memorial Foundation
Japan Intractable Diseases Research Foundation
Japan Rheumatic Disease Foundation
Text and Data Mining valid from 2018-06-12
Received: 13 November 2017
Accepted: 30 April 2018
First Online: 12 June 2018
Ethics approval and consent to participate
: The study protocol and genetic analyses were approved by Yokohama City University Ethics Board (A140327015 and B131107009). All of the human samples were used after written informed consent was obtained.
: MT serves as an advisor for the apremilast clinical trial for Celgene.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.